These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31376244)

  • 21. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
    Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
    J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Referral and experience with genetic testing among women with early onset breast cancer.
    Brown KL; Hutchison R; Zinberg RE; McGovern MM
    Genet Test; 2005; 9(4):301-5. PubMed ID: 16379543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.
    Bowen DJ; Burke W; Yasui Y; McTiernan A; McLeran D
    Genet Med; 2002; 4(5):359-65. PubMed ID: 12394349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
    Chopra I; Kelly KM
    J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
    Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
    Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer.
    Gammon AD; Rothwell E; Simmons R; Lowery JT; Ballinger L; Hill DA; Boucher KM; Kinney AY
    J Genet Couns; 2011 Dec; 20(6):625-38. PubMed ID: 21691939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Knowledge and willingness of breast cancer patients from Shanghai for genetic counseling and gene testing].
    Cheng X; Li Z; Sun X; Jiang B; Zhuang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):589-93. PubMed ID: 27577200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
    Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey.
    Turbitt E; Roberts MC; Taber JM; Waters EA; McNeel TS; Biesecker BB; Klein WMP
    Prev Med; 2019 Jun; 123():12-19. PubMed ID: 30817954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disclosure of research results: a randomized study on GENEPSO-PS cohort participants.
    Mancini J; Le Cozannet E; Bouhnik AD; Resseguier N; Lasset C; Mouret-Fourme E; Noguès C; Julian-Reynier C
    Health Expect; 2016 Oct; 19(5):1023-35. PubMed ID: 26205609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single-country, multi-center, patient-reported outcome study.
    Kuo WL; Lin PH; Peng MT; Chu CH; Cho CW
    J Genet Couns; 2023 Aug; 32(4):788-797. PubMed ID: 36872635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.
    Klemp JR; O'Dea A; Chamberlain C; Fabian CJ
    Fam Cancer; 2005; 4(4):279-84. PubMed ID: 16341803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
    Flores KG; Steffen LE; McLouth CJ; Vicuña BE; Gammon A; Kohlmann W; Vigil L; Dayao ZR; Royce ME; Kinney AY
    J Genet Couns; 2017 Jun; 26(3):480-490. PubMed ID: 27496122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
    Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
    Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.
    Gray SW; O'Grady C; Karp L; Smith D; Schwartz JS; Hornik RC; Armstrong K
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1303-11. PubMed ID: 19318436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
    JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis of telephone vs in-person genetic counseling in BRCA1/BRCA2 genetic testing.
    Bracke X; Roberts J; McVeigh TP
    J Genet Couns; 2021 Apr; 30(2):563-573. PubMed ID: 33131182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
    Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
    J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.